Phibro Animal Health Corporation (PAHC)

Days of sales outstanding (DSO)

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Receivables turnover		5.86	6.00	6.33	6.41	5.87	6.26	6.28	6.62	5.62	5.80	6.17	6.06	5.67	5.89	6.33	6.42	6.33	5.40	5.52	5.62
DSO	days	62.23	60.81	57.70	56.98	62.15	58.32	58.13	55.12	64.97	62.99	59.14	60.19	64.32	61.93	57.65	56.83	57.70	67.60	66.17	64.93

June 30, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.86
= 62.23

Days Sales Outstanding (DSO) is a metric used to measure the average number of days it takes for a company to collect payment after making a sale. A lower DSO indicates that the company is collecting payments more quickly, which can be a sign of efficient cash flow management.

Analyzing Phibro Animal Health Corporation's DSO over the past few quarters, we observe fluctuations in the metric. In the most recent quarter, ending June 30, 2024, the DSO was 62.23 days, which was slightly higher than the previous quarter at 60.81 days. This increase may indicate a slower collection of receivables in the current period compared to the previous one.

Looking back further, DSO has varied between a low of 55.12 days in the quarter ending September 30, 2022, and a high of 67.60 days in the quarter ending September 30, 2019. These fluctuations suggest some degree of volatility in the company's receivables collection process over time.

Overall, while Phibro Animal Health Corporation's DSO has shown some inconsistencies, it is essential to monitor trends and identify any persistent patterns that may impact the company's cash flow and working capital management. Investors and analysts should continue to assess the company's receivables management strategies to ensure efficiency in collecting payments from customers.